News

As Covid-19 restrictions continue in the UK, we are glad to report that Fleet Bioprocessing Ltd. are still able to provide all our usual services. With strict hygiene arrangements and staff working at home wherever possible, we have managed to keep our labs in operation throughout this crisis - with turnaround times close to normal. We look forward to continuing to help our customers through this difficult time.

Fleet Bioprocessing Ltd. are proud to report that we received zero non-conformances in our latest audit against the requirements of ISO9001: 2015 and ISO13485: 2016, which was carried out by NQA in October.

Fleet Bioprocessing Ltd. are pleased to announce that our accreditation to ISO9001: 2015 and ISO13485: 2016 is now being handled by NQA, one of the world's leading certification bodies. You can find our new certificates here . Of course, there will be no change to our existing quality standards, which will always meet the highest industry and regulatory requirements...

Fleet Bioprocessing is proud to announce that it has achieved Cyber Essentials accreditation. Cyber Essentials is a Government backed scheme designed to protect organisations and their data from the vast majority of common cyber attacks and online threats. A copy of our certificate can be found here.

We are delighted to announce that Dr. Christopher Blencowe has been appointed to the Board of Fleet Bioprocessing Ltd., in the role of Chemistry Director. Before Chris joined the company in 2013, he had completed a PhD in physical organic chemistry at the University of Reading, then worked for Unilever on polymer conjugation and the development of emulsion polymers. Chris has managed Fleet's chemistry team since 2018, and will now be able to contribute more broadly to the Com

The University of South Australia (UniSA) is among the 2019 recipients of a Global Connections Fund award, for a collaboration with Fleet Bioprocessing Ltd. to develop trifunctional bioconjugation reagents for innovative medical and biotech applications. This fund is administered by the Government of Australia to help develop the country’s economy via international partnerships; Minister for Industry, Science and Technology, Karen Andrews said: “Through this fund we are suppo

Fleet Bioprocessing Ltd. announce Innovate UK funding for new larger project on immunoassay conjugate characterisation, in collaboration with the National Physical Laboratory and LGC Ltd. Following on from a successful 3-month initial project completed in March 2019, further funding has been confirmed under the Innovate UK Analysis for Innovators scheme for a more comprehensive 12-month follow-up project. Led by Fleet Bioprocessing Ltd. and entitled Rapid and Inexpensive Cha

Fleet Bioprocessing Ltd. are pleased to report the successful completion of their Innovate UK-funded collaboration with the National Physical Laboratory (NPL) and LGC Ltd. A three month exploratory project entitled “Faster and Cheaper Techniques for the Characterisation of Immunoassay Conjugates” , this project was funded under the Analysis for Innovators (A4I) programme, and has identified a number of promising analytical techniques for further evaluation.   All three pa

Fleet Bioprocessing Ltd. along with research partners LGC Limited and the National Physical Laboratory (NPL) have successfully acquired funding from Innovate UK, the UK’s Innovation Agency, to investigate “Faster and Cheaper Techniques for Characterisation of Immunoassay Conjugates” . Using expertise from LGC on hydrogen/deuterium exchange mass spectrometry (HDX-MS) and ion mobility spectrometry mass spectrometry (IMS-MS) and from NPL on circular dichroism spectroscopy (CD),